Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Open Access
    Datensatz exportieren als...
  • BibTeX
Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer
Cancer research (Chicago, Ill.), 2015-11, Vol.75 (22), p.4863-4875
2015
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-08-23: Disclosure of familial implications of pathogenic BRCA1/2 to probands: Opportunity for prompting family communication
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-23
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PS8-28: Outreach to families with known BRCA mutation through the reach (research, education, and awareness of cancer family history) registry
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS8-28-PS8-28
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-08-26: Clinical characteristics of breast cancer patients with ATM mutations
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-26
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-08-06: Characteristics of ductal carcinoma in situ (DCIS) in patients who underwent multigene panel testing for hereditary breast cancer
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P6-P6-08-06
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PS4-31: Characteristics of HER2/ neu positive breast cancer among patients with and without germline BRCA mutations
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS4-31-PS4-31
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PS8-04: Clinical and pathological characteristics and screening outcome for secondary cancers in breast cancer patients with li-fraumeni syndrome attending the MD anderson li-fraumeni education and early detection program clinic
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS8-04-PS8-04
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PS11-03: Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: A subgroup analysis of germline BRCA1 or BRCA2 mutations from the phase 3 BROCADE3 trial
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-03-PS11-03
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P2-16-09: Residual cancer burden in patients with early stage triple negative breast cancer who progress on anthracycline-based neoadjuvant chemotherapy in an ongoing clinical trial (ARTEMIS)
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-16-09
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P2-09-04: Reclassification of variant of unknown significance in BRCA1 and BRCA2 genes based on loss of heterozigosity assay
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-09-04
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PD4-01: First-line veliparib plus carboplatin/paclitaxel in patients with HER2-negative advanced/metastatic g BRCA -associated breast cancer: Planned subgroup analysis from the phase 3 BROCADE3 trial
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.PD4-01-PD4-01
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P1-10-20: Serial TILs: Evaluating the role of mid-treatment tumor infiltrating lymphocytes (TIL) in predicting pathologic complete response (pCR) in early-stage triple negative breast cancer (TNBC)
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-10-20
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P3-03-06: Prediction of response to neoadjuvant systemic therapy in triple negative breast cancer using baseline tumor MRI characteristics and imaging patterns of response
Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-03-06
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract 2192: Single-molecule single-cell DNA sequencing identifies ongoing copy number evolution in BRCA breast cancers
Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2192-2192
2018
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PS18-04: Prospective evaluation of patients with metaplastic (Mp) triple negative breast cancer (TNBC): Molecular characteristics and outcomes with neoadjuvant therapy (NAT)
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-04-PS18-04
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PS4-05: Prospective evaluation of the gut microbiome and response to neoadjuvant therapy (NAT) in early-stage triple negative breast cancer (TNBC)
Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS4-05-PS4-05
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P1-05-26: A blood-based lipid panel for personalized risk assessment of breast cancer
Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P1-P1-05-26
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract P6-02-04: Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes
Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P6-P6-02-04
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract PO-133: Breast tumors maintain a reservoir of subclonal diversity during primary expansion
Cancer research (Chicago, Ill.), 2020-11, Vol.80 (21_Supplement), p.PO-133-PO-133
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT3-15-02: A randomized, double-blind, placebo-controlled study of 4-hydroxytamoxifen topical gel in women with mammographically dense breasts
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT3-15-02-OT3-15-02
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract GS6-03: Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in germline BRCA mutation carriers ( BRCA carriers) with HER2-negative breast cancer: Results from the INFORM trial (TBCRC 031)
Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS6-03-GS6-03
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract 5240: Validation of research cohort based penetrance estimates for multiple cancer types and multiple primary cancers on clinically ascertained families
Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5240-5240
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT2-13-01: Willingness to Participate in a Trial Comparing Standard Genetic Counseling versus Genetic Counseling with Personalized Cancer Risks Estimates in Patients with Li-Fraumeni Syndrome
Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT2-13-01-OT2-13-01
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract OT2-12-01: Clinical Application of LFSPRO: A Prospective Study
Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT2-12-01-OT2-12-01
2023
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Abstract 3218: Zyflamend, a multi-herbal product, selectively inhibits the growth of triple negative breast cancer cells in vitro
Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3218-3218
2014
Volltextzugriff (PDF)
1 – 25 von 35
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieCancer Research
Suchergebnisse filtern
Filter anzeigen